Login
Home
Charts
Search
Watchlist
Products

Dipna Pharmachem Ltd

DPL·BSE
₹4.83+4.77%Tue, 22 Sept '26
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Dipna Pharmachem Ltd

DPL
BSE
₹4.83
+4.77%
|Tue, 22 Sept '26
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹13Cr
Close
Close Price
₹4.84
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
4.84
PS
Price To Sales
0.10
Revenue
Revenue
₹129Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2025Dec 2025Mar 2026
Revenue
RevenueCr
16542
Growth YoY
Revenue Growth YoY%
-87.1
Expenses
ExpensesCr
15522
Operating Profit
Operating ProfitCr
120
OPM
OPM%
8.03.121.9
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
100
Depreciation
DepreciationCr
000
PBT
PBTCr
110
Tax
TaxCr
000
PAT
PATCr
110
Growth YoY
PAT Growth YoY%
-64.0
NPM
NPM%
3.11.98.8
EPS
EPS₹
0.20.40.1
QuarterMar 2025Dec 2025Mar 2026
Revenue
RevenueCr
16542
Growth YoY
Revenue Growth YoY%
-87.1
Expenses
ExpensesCr
15522
Operating Profit
Operating ProfitCr
120
OPM
OPM%
8.03.121.9
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
100
Depreciation
DepreciationCr
000
PBT
PBTCr
110
Tax
TaxCr
000
PAT
PATCr
110
Growth YoY
PAT Growth YoY%
-64.0
NPM
NPM%
3.11.98.8
EPS
EPS₹
0.20.40.1

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
1720313173100164125129
Growth
Revenue Growth%
21.951.31.5134.737.464.5-24.03.4
Expenses
ExpensesCr
172030317198161121124
Operating Profit
Operating ProfitCr
000022335
OPM
OPM%
0.30.30.21.33.02.32.12.83.9
Other Income
Other IncomeCr
00000000
Interest Expense
Interest ExpenseCr
000011221
Depreciation
DepreciationCr
000000000
PBT
PBTCr
000021114
Tax
TaxCr
000000001
PAT
PATCr
000011113
Growth
PAT Growth%
-47.084.3-59.04,721.8-21.919.0-10.3170.0
NPM
NPM%
0.40.20.20.11.60.90.70.82.0
EPS
EPS₹
17.39.216.96.9333.40.60.90.41.0
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
1720313173100164125129
Growth
Revenue Growth%
21.951.31.5134.737.464.5-24.03.4
Expenses
ExpensesCr
172030317198161121124
Operating Profit
Operating ProfitCr
000022335
OPM
OPM%
0.30.30.21.33.02.32.12.83.9
Other Income
Other IncomeCr
00000000
Interest Expense
Interest ExpenseCr
000011221
Depreciation
DepreciationCr
000000000
PBT
PBTCr
000021114
Tax
TaxCr
000000001
PAT
PATCr
000011113
Growth
PAT Growth%
-47.084.3-59.04,721.8-21.919.0-10.3170.0
NPM
NPM%
0.40.20.20.11.60.90.70.82.0
EPS
EPS₹
17.39.216.96.9333.40.60.90.41.0

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0000012242426
Reserves
ReservesCr
0011212131436
Current Liabilities
Current LiabilitiesCr
1114182129428385133
Non Current Liabilities
Non Current LiabilitiesCr
000461113910
Total Liabilities
Total LiabilitiesCr
111418253678133132206
Current Assets
Current AssetsCr
111418253678133132154
Non Current Assets
Non Current AssetsCr
0000000052
Total Assets
Total AssetsCr
111418253678133132206
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0000012242426
Reserves
ReservesCr
0011212131436
Current Liabilities
Current LiabilitiesCr
1114182129428385133
Non Current Liabilities
Non Current LiabilitiesCr
000461113910
Total Liabilities
Total LiabilitiesCr
111418253678133132206
Current Assets
Current AssetsCr
111418253678133132154
Non Current Assets
Non Current AssetsCr
0000000052
Total Assets
Total AssetsCr
111418253678133132206

Cash Flow

Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-3-23-21-5-9-18
Investing Cash Flow
Investing Cash FlowCr
0000000
Financing Cash Flow
Financing Cash FlowCr
33-32614-419
Net Cash Flow
Net Cash FlowCr
00058-130
Free Cash Flow
Free Cash FlowCr
-3-23-21-5-9
CFO To PAT
CFO To PAT%
-5,283.6-10,051.2240.4-2,300.3-499.1-943.9-696.6
CFO To EBITDA
CFO To EBITDA%
-5,308.0-608.4128.9-895.3-158.0-267.7-364.9
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-3-23-21-5-9-18
Investing Cash Flow
Investing Cash FlowCr
0000000
Financing Cash Flow
Financing Cash FlowCr
33-32614-419
Net Cash Flow
Net Cash FlowCr
00058-130
Free Cash Flow
Free Cash FlowCr
-3-23-21-5-9
CFO To PAT
CFO To PAT%
-5,283.6-10,051.2240.4-2,300.3-499.1-943.9-696.6
CFO To EBITDA
CFO To EBITDA%
-5,308.0-608.4128.9-895.3-158.0-267.7-364.9

Ratios

Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1523342113
Price To Earnings
Price To Earnings
16.520.934.98.04.8
Price To Sales
Price To Sales
0.10.10.30.20.1
Price To Book
Price To Book
0.60.60.90.30.2
EV To EBITDA
EV To EBITDA
10.88.214.96.64.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
7.06.65.04.55.34.33.98.9
OPM
OPM%
0.30.30.21.33.02.32.12.83.93.9
NPM
NPM%
0.40.20.20.11.60.90.70.82.02.0
ROCE
ROCE%
1.30.80.63.118.35.86.06.26.66.6
ROE
ROE%
13.26.610.84.267.13.72.92.54.24.2
ROA
ROA%
0.60.20.30.13.21.20.80.71.31.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1523342113
Price To Earnings
Price To Earnings
16.520.934.98.04.8
Price To Sales
Price To Sales
0.10.10.30.20.1
Price To Book
Price To Book
0.60.60.90.30.2
EV To EBITDA
EV To EBITDA
10.88.214.96.64.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
7.06.65.04.55.34.33.98.9
OPM
OPM%
0.30.30.21.33.02.32.12.83.93.9
NPM
NPM%
0.40.20.20.11.60.90.70.82.02.0
ROCE
ROCE%
1.30.80.63.118.35.86.06.26.66.6
ROE
ROE%
13.26.610.84.267.13.72.92.54.24.2
ROA
ROA%
0.60.20.30.13.21.20.80.71.31.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Dipna Pharmachem Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/oabbmz5okxk6uiv31dbtlkf7.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/11sho6oq1qal78xb9qrwwn7u.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/nrh0r5ft62218nxc9cznwdh8.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/vjqv3t23fyuoylq86c43h285.pdf
  • Q2 FY2024 Quarterly Result (Sep 2023, PDF): https://www.stockscans.in/document/z8tayv46isggmkdhdjl4wmk7.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/ykwl6u8igus4u5brtmric2xy.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/y8qjjn6nkj1n1dl1prnl5n0u.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/vgxxlzet7wr8doyzh1onncoc.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies